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Distinct cell proliferation events during abstinence after alcohol
dependence: microglia proliferation precedes neurogenesis
K. Nixon†, D. H. Kim, E. N. Potts, J. He, and F. T. Crews*
Abstract
Excessive alcohol intake characteristic of Alcohol Use Disorders (AUDs) produces
neurodegeneration that may recover with abstinence. The mechanism of regeneration is unclear,
however neurogenesis from neural stem/progenitor cells is a feasible mechanism of structural
plasticity. Therefore, a timecourse of cell proliferation was examined in a rat model of an AUD and
showed a striking burst in cell proliferation at 2 days of abstinence preceding the previously reported
neurogenic proliferation at 7 days. New cells at 2 days, assessed by Bromo-deoxy-Uridine
incorporation and endogenous markers, were observed throughout hippocampus and cortex.
Although the majority of these new cells did not become neurons, neurogenesis was not altered at
this specific timepoint. These new cells expressed a microglia specific marker, Iba-1, and survived
at least 2 months. This first report of microglia proliferation in a model of an AUD suggests that
microgliosis could contribute to volume recovery in non-neurogenic regions during abstinence.
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Over 8.5% of the U.S. population meets the diagnostic criteria for an alcohol use disorder
(AUD), commonly termed alcoholism (Grant et al., 2004). AUDs result in cognitive deficits
that correspond to various functional and structural neuropathologies (Sullivan and
Pfefferbaum, 2005). Impairments in hippocampal functions such as short term and declarative
memory, spatial learning and memory, and impulsivity suggest hippocampal pathology
(Brandt et al., 1983; Parsons, 1993; Stephens et al., 2005; Sullivan et al., 2000a;b) though
observations of such in human alcoholics vary: some report hippocampal cell or volume loss
(Agartz et al., 1999; Beresford et al., 2006; Laakso et al., 2000; Sullivan et al., 2000a) but not
others (Harding et al., 1997; Kril et al., 1997). Cortical neurodegeneration in alcoholics is more
consistently reported, with impairments across psychometric, cognitive, imaging, volume and
cell number analyses (Kril et al., 1997; Sullivan and Pfefferbaum, 2005). Alcoholic
neurodegeneration may reverse with abstinence and is often accompanied by improved
cognitive performance (Bartels et al., 2007; Sullivan et al., 2000a), however the mechanism
of this recovery is not understood. The observation of this structural plasticity in the brain
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following alcohol dependence lead to the question of whether a recently described mechanism
of structural plasticity, the regulation of neural stem/progenitor cells (NSCs), may contribute
to neuroregeneration in AUDs.
The phenomenon of NSCs producing new neurons in adult brain, adult neurogenesis, is well-
accepted in two regions of the normal brain: (1) the subgranular zone (SGZ) of the hippocampal
dentate gyrus (Altman and Das, 1965; Palmer et al., 1997) and (2) the subventricular zone
(SVZ) of the anterior lateral ventricles (Lois and Alvarez-Buylla, 1993). The significance of
adult neurogenesis is suggested by the thousands of new granule cells generated daily
(Cameron and McKay, 2001); by its conservation across species including humans (Eriksson
et al., 1998) and by the correlation between hippocampal dysfunction and altered neurogenesis
(Cameron and Gould, 1994; Eisch, 2002; Nixon, 2006; Warner-Schmidt and Duman, 2006).
Regulation of NSCs/neurogenesis as a means of structural plasticity has been suggested to
contribute to hippocampal dysfunction in psychiatric disease (Eisch, 2002; Ming and Song,
2005). Indeed, alcoholics demonstrate impaired cognition and animal models have shown that
alcohol intoxication reduces adult neurogenesis at levels similar to the extent of granule cell
loss in the dentate gyrus (Nixon and Crews, 2002; Walker et al., 1980). Conversely, a reactive
burst in neurogenesis occurs at 1 week in abstinence (Nixon and Crews, 2004). However, NSC
proliferation was restricted to the dentate gyrus and does not explain cortical regeneration. As
this reactive neurogenesis event is similar to that of other brain damage models where multiple
bursts in cell proliferation occur following injury (e.g. Ernst and Christie, 2006) and previous
investigations only investigated limited timepoints, we investigated a full timecourse of cell
proliferation events in ethanol withdrawal in a model of an AUD. This investigation led to the
striking finding of an earlier and more widespread burst in cell proliferation that precedes the
neurogenic proliferation event at 1 week of abstinence.
Materials and methods
Subjects
Data from 73 adult male Sprague-Dawley rats (Charles River; Raleigh, NC) weighing in range
of 270 – 365g are reported in this study. BrdU and animal model data from the T72, T168, T2
wk and T4wk timepoint were reported previously (Nixon and Crews, 2004) but are included
in this report to show the complete timeline of effects of ethanol on cell proliferation (Figure
1 and Table 2 only). Rats were kept on a 12h light: 12h dark cycle with ad libitum access to
food and water except during binge alcohol treatment where food was removed. All animal
procedures followed the Guide for the Care and Use of Laboratory Animals and were approved
by the University of North Carolina Institutional Animal Care and Use Committee.
Alcohol Use Disorder Model - Binge Alcohol Treatment
Ethanol was administered in a binge paradigm following established methods reported in detail
elsewhere (Knapp and Crews, 1999; Majchrowicz, 1975; Nixon and Crews, 2004). In brief,
rats were administered ethanol diet (25% ethanol w/v in Vanilla Ensure®) or isocaloric control
diet via gastric intubation every 8 h for 4 days. Rats were given an initial priming dose of 5 g/
kg with subsequent doses determined by a six-point behavioral intoxication scale: 0 – normal
rat (dose=5 g/kg); 1 – hypoactive (4 g/kg); 2 – ataxia (3 g/kg); 3 - ataxia with dragging abdomen
and/or delayed righting reflex (2 g/kg); 4 – loss of righting reflex (1 g/kg); and 5 – loss of eye
blink reflex (0 g/kg). Eight hours after the last dose of alcohol, rat chow was returned to all
cages and alcohol withdrawal behaviors were observed and scored from 10 h after the last dose
(i.e. T10) through T24, the period of peak withdrawal symptoms for this exposure model
(Knapp et al., 1993; Nixon and Crews, 2004; Penland et al., 2001).
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To determine blood ethanol concentrations, tail blood samples were drawn 90 m after the
afternoon dose on the second day of the binge. Blood samples were centrifuged to separate
serum and samples were frozen at −20°C until analysis. Blood ethanol concentrations were
determined from serum by a GM7 Analyser (Analox, London, UK) and reported in mg/dl ±
SEM.
Bromodeoxyuridine (BrdU) labeling
To show a timecourse of changes in cell proliferation after ethanol exposure, a 300 mg/kg (i.p.)
dose of BrdU was used to label dividing cells in rats sacrificed at various times. BrdU (Sigma;
20 mg/ml in 0.9% saline) was injected four hours before various sacrifice time points after the
last dose of ethanol: 24 h (T24; BrdU at 20 h after the last dose), 48 h (T48), 72h (T72), 96h
(T96), 168h (T168), and at 14 days (T2wk) and 28 days (T4wk). Time points were chosen
based on previous studies of other types of neurodegenerative events (Liu et al., 1998; Parent
et al., 1997). To examine changes in neurogenesis (BrdU-positive cell survival and cell
phenotype), a single dose of BrdU was administered (300 mg/kg, i.p.) and rats were allowed
to survive for 28 days. Specifically, rats were injected at T48h (Day 2) and allowed to survive
to Day 30, referred to as “T48h + 28 days” or Day 58 “T48 + 2 mos.”
Tissue preparation
Animals were deeply anesthetized with ketamine/xylazine cocktail and transcardially perfused
with 0.1M phosphate buffered saline (pH 7.4) followed by 4% paraformaldehyde (PFA) as
described (Knapp and Crews, 1999; Nixon and Crews, 2002). Brain tissue was harvested and
postfixed in 4% PFA for 2 hours. A 1:12 series of coronal sections (40 µm) were collected on
a vibrating microtome (Leica VT1000S) and stored in cryoprotectant at −20°C until
immunohistochemical labeling. Sections were obtained from approximately Bregma 1.2
(random start point) through Bregma −7.0 which yielded tissue for the entire dentate gyrus and
portions of the subventricular zone (SVZ).
Immunohistochemistry
For general immunohistochemistry, every 12th section was processed following standard
procedures for DAB detection (reagent concentrations vary by antibody). In brief, endogenous
peroxidases were quenched by incubation in a 0.6% – 1% H2O2 in TBS. Sections were blocked
in TBS+ (TBS / 0.1% triton-X / 3–10% normal serum) for 30 m and incubated at 4°C for 24–
48 h in primary antibody diluted in TBS+ as shown in Table 1. With washes between each
step, the sections were incubated with appropriate biotinylated secondary antibody (Table 1)
for 1 h followed by avidin-biotin-peroxidase complex (ABC elite kit, Vector) and detected
with Nickel-enhanced diaminobenzidine as a chromagen. Ki-67 labeled sections were lightly
countered stained with Neutral Red and all sections were coverslipped with mounting medium
(Cytoseal®). For BrdU immunohistochemistry, every 6th section (240 µm apart) was processed
following the methods of Kuhn et al. (Kuhn et al., 1996) with an additional denaturing step as
reported previously (Nixon and Crews, 2002). Sections were lightly counterstained with cresyl
violet and coverslipped with Cytoseal®. In all cases, specificity of the antibody was verified
by control experiments: omission of primary antibody, BrdU injection, or secondary antibody.
Fluorescent Immunohistochemistry
To determine cell differentiation, double or triple fluorescent immunohistochemistry was
performed on every 12th section similar to that previously described (Kuhn et al., 1997; Nixon
and Crews, 2004). In brief, DNA was denatured (without DNase), sections were blocked in
TBS+ (TBS/3% goat serum/0.1% triton-X) for 1 h, and incubated 24–48 h at 4°C rat anti-BrdU,
mouse anti-NeuN, and rabbit anti-GFAP or rabbit anti-Iba-1 or double labeling only of rat anti-
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BrdU and rabbit anti-Iba-1. Following washes in TBS+, sections were incubated for 1 h in
fluorescent-coupled secondary antibodies at room temperature (Alexa Fluor as listed in Table
1; Molecular Probes) plus 1.5% goat serum. Sections were washed in TBS, mounted and dried,
then coverslipped with anti-fade mounting medium (Pro-Long Gold, Molecular Probes).
Quantification
All brains were coded; therefore the experimenter was blind to the conditions during all staining
and quantification procedures. Three subjects were removed from the study for insufficient
BrdU labeling (Eisch et al., 2000). Quantification of immunopositive profiles was via profile
counting for dentate gyrus (Fig 1, Fig 7b) and via image analysis for cortical and other
hippocampal regions using methods identical to that previously reported (Crews et al., 2004;
Nixon and Crews, 2004). Stereological quantification methods were not used as BrdU-positive
(BrdU+) cells are not homogenously distributed (Popken and Farel, 1997) and the data of
interest is relative difference and not absolute value (Guillery and Herrup, 1997). Further,
stereological estimations, profile counts and/or densitometric analyses show identical results
in percent change, the measure of interest (Crews et al., 2004). Briefly, to assess BrdU
immunohistochemistry in the dentate gyrus, the number of BrdU+ cells was counted in the
granule cell layer and SGZ (50 µm ribbon between the granule cell layer and hilus) of the dorsal
dentate gyrus (Bregma −1.8 to−5.8) at 1200X with an oil immersion lens (Olympus Plan Apo
60X oil, numerical aperture = 1.4). The area of the granule cell layer and SGZ was then obtained
by tracing the region at 42.5X with image analysis software (Bioquant Nova Advanced Image
Analysis, R&M Biometric, Nashville, TN). Cell counts were divided by the area of the traced
region, expressed as cells/mm2 ± SEM, and analyzed by ANOVA. For regions with vast BrdU-
immunoreactivity (BrdU+IR) such as other hippocampal regions, cortical regions and the SVZ,
BrdU+IR (densitometry) was measured with Bioquant image analysis software identical to
past reports (Crews et al., 2004; Crews et al., 2006c). The pattern of BrdU immunoreactivity
was verified with the endogenous cell proliferation marker, Ki-67 (Kee et al., 2002).
The co-labeling of BrdU with neuron-specific (NeuN), glia-specific (GFAP), or microglia-
specific (Iba-1) proteins was confirmed by confocal microscopy as described in Nixon and
Crews (2004). Briefly, a Zeiss Axiovert LSM510 confocal microscope and water immersion
lens (C-Apochromat 40x/1.2 W corr) was used to take Z-plane section images of BrdU+ cells
in a minimum of 5 tissue sections for each subject. The number of BrdU+ cells examined varied
by region, treatment group, and subject (due to variability in extent of cell proliferation). A
minimum of 50 cells were analyzed in the dentate gyrus of both ethanol and control brains. In
other regions where cell proliferation is not common as many cells as feasible were examined.
In each ethanol-exposed brain, approximately 40 cells were examined in the hilus, 20 in CA1,
20 in CA2, 30 in the molecular layer, and 20 in cortical regions (somatosensory and entorhinal
cortices). For each control brain, fewer cells were present and therefore fewer cells were
examined. Typically, five to ten cells were analyzed per non-neurogenic region per control
brain. Z-plane section images (512 × 512 pixels) were collected at <0.8µm thickness then
analyzed using LSM Image Examiner software. The criteria for co-labeling included
appropriate, aligned morphology in 3-D reconstructed cells (orthogonal function) and greater
than two Z-plane images of co-positive staining from each axis. Co-localization with NeuN,
GFAP or Iba-1 was reported as a percentage of the number of BrdU+ cells that colocalized
with each marker. The numberof BrdU+ cells at T48 + 28 days was counted at 400x (profile
counts) using an Olympus BX-51 microscope with FITC filter cube and expressed as the
number of cells per section. Values of “calculated cell genesis” were computed by multiplying
this number of BrdU+ cells by the co-localization percentages as an estimate of neurogenesis
and/or gliogenesis.
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Statistical analyses were conducted in StatView (Mac v 5.0.1, Abacus Concepts, Berkeley,
CA) or Prism (GraphPad Prism v4, San Diego, CA). Cell counts, blood ethanol measurements
and immunoreactivity measures were analyzed by ANOVA followed by Fisher’s PLSD
posthoc tests. For BrdU+IR in cortical regions, where variance was statistically different
between the two groups (F-test, p<0.05), all values were log transformed to normalize the data.
All two-group comparisons were analyzed by t-test. Behavioral scores (intoxication,
withdrawal severity) were compared by nonparametric Kruskall-Wallis analysis of variance.
BrdU+ cell counts were correlated to various intoxication measures and reported with Pearson
or Spearman r as appropriate. In all cases, values were reported as mean ± SEM and differences
were considered significant at p<0.05.
Results
Alcohol model data
A comparison of alcohol intake and withdrawal data for subjects in the proliferation timecourse
shows that rats were significantly intoxicated as evidenced by blood ethanol concentrations
(BEC), Ethanol intake (g/kg/day), and behavioral intoxication scores (see Table 2). For BECs,
serum was obtained from tail blood samples ~90 min after the afternoon dose of ethanol on
Day 2 of the binge. The grand mean BEC for all animals in this study was 300.5 ± 14.1 mg/
dl, which corresponded to the grand mean dose of 9.2 ± 0.2 g/kg/day. This average dose per
day is similar to that of rat self-administration models (Lukoyanov et al., 2000) and more
importantly, the BECs are similar to that of bingeing alcoholics (Adachi et al., 1991;Minion
et al., 1989;Urso et al., 1981). All ethanol-treated groups were similar in ethanol intoxication
parameters evidenced by similar BECs, doses and intoxication behaviors as shown in Table 2.
As withdrawal from alcohol produces a well-described syndrome that can include seizures
(Hall and Zador, 1997), and seizures alter NSC proliferation and neurogenesis in other models,
we observed and scored withdrawal behaviors from 10 h after the last dose through 24 h.
Withdrawal behavior was scored using the scale described in Penland et al. (2001) ranging
from 0.0 for no overt signs or behaviors to 3.8 for tonic-clonic seizure-like behavior. Of the
42 rats assessed for ethanol withdrawal behaviors, 95% (n=40) demonstrated behaviors
consistent with withdrawal and 38% (n=16) showed seizure-like behavior, percentages similar
to past reports (Majchrowicz, 1975; Nixon and Crews, 2004). As reported in Table 2, both
peak and mean withdrawal scores were similar between time point groups. Thus, withdrawal
severity was statistically similar between all groups.
Cell Proliferation during Ethanol Withdrawal and Abstinence
The aforementioned model of physical dependence was used to examine the effects of high,
intoxicating doses of alcohol on cell proliferation in the subgranular zone of the dentate gyrus,
a region that contains NSCs (Palmer et al., 1997). The subgranular zone is defined as an
approximate 50µm ribbon between the granule cell layer and the hilus. Following four-days
of binge alcohol exposure, BrdU was injected to label dividing cells at several time points
following the last dose of alcohol. In all cases, clusters and individual BrdU+ cells were visible
in the subgranular zone as expected. Therefore, BrdU+ cell counts were conducted first in the
dentate gyrus and subgranular zone from the seven time points examined after binge ethanol
exposure thus far. As is evident in Figure 1, dramatic differences existed in the number of BrdU
+ cells/area [F(7,47)=3.065, p=0.0096] between ethanol and control brains, with posthoc tests
confirming significant increases in BrdU+ cells at T48 (p=0.0039) and T168 (p=0.0008)
following binge ethanol exposure.
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Because a striking pattern of BrdU-immunoreactivity was noted in the hippocampus and
cortical regions of T48 binge exposed tissue, additional regions of interest were determined
from visual observations of aberrant BrdU-immunoreactivity. All hippocampal subregions
(other than dentate gyrus reported above) and cortical regions where distinct BrdU+ cells were
easily visualized were then examined for BrdU-immunoreactivity. The immunoreactivity
measure was chosen because of the vast number of BrdU+ cells in these regions. As shown in
Figure 2, a significant increase in BrdU immunoreactivity (BrdU+IR) is observed across most
subregions of the hippocampus including the molecular layer (p<0.0003), CA1 (p<0.0006),
and CA2/3 regions (p<0.012). And though the hilus showed an eight-fold increase in BrdU
+IR it was not statistically significant (p=0.10). No particular pattern in or around neuronal
layers can be observed, an effect that is supported by staining for Ki-67, an endogenous marker
of cell proliferation (Figure 2D, E). Ki-67 labels all cells that are actively dividing, that is not
G0 phase, the resting phase (Kee et al., 2002). Only two distinct cortical regions among those
examined (Figure 3) show significantly increased BrdU+IR in ethanol-exposed brains at T48
compared to controls, specifically the motor cortex (p=0.025), and somatosensory (p=0.038).
And though BrdU+IR is increased by four-fold in ethanol-exposed retrosplenial cortex at T48,
the effect is not statistically significant (p=0.08). As BrdU+IR was aberrantly increased at this
particular time point after ethanol exposure, we also assessed BrdU+IR in the frontal
neurogenic region, the subventricular zone. BrdU+IR was not different between binge ethanol-
exposed (438.1 ± 102.5 pixels/mm2) and controls (506.2 ± 8.0 pixels/mm2) in the
subventricular zone at T48, which suggests that this cell proliferation effect is regionally
distinct.
To examine survival and differentiation of new cells labeled at T48, a second binge experiment
was performed: Rats were exposed to binge ethanol or control diet for four days injected with
BrdU at T48 then allowed to survive for 28 days. Twenty-eight days is the point at which most
newborn cells express a mature cell phenotype and are considered to become permanently
incorporated (Kempermann et al., 2003). The initial visual inspection of ethanol-exposed tissue
again revealed a striking pattern of BrdU+ cells in both hippocampal and cortical regions. Due
to the vast labeling, immunoreactivity was measured for all regions. As shown in Figure 4A,
BrdU+IR is significantly increased in all regions of the binge ethanol-exposed hippocampus
at 28 days after BrdU injection at T48 (p<0.05 for all regions). Again, no distinct pattern in or
around neuronal layers or subregions can be discerned and the BrdU label is dense and
triangular in most regions, which is quite unlike what is typically observed in newborn BrdU
+ neurons of the dentate gyrus granule cell layer (Figure 4A, Figure 5 E, F). Strikingly, BrdU
+IR was observed in more cortical regions after 28 days than in the proliferation time point
(Figure 3), therefore many regions were assessed for BrdU+IR. As shown in figure 4B, BrdU
+IR was significantly increased in the auditory, entorhinal motor, parietal, perirhinal,
retrosplenial, somatosensory, temporal, and visual cortices with merely a trend indicated for
insular cortex (p=0.06) and cingulate cortex (p=0.08) as well as in the caudate putamen
(p=0.08). Importantly, the same cortical regions that showed significant increases in BrdU+IR
at T48, were also significantly increased at T48 + 28 days. However, several additional cortical
regions had BrdU+ cells at this time point. To confirm whether these cells persisted long term,
an additional timepoint was created: rats were exposed to binge ethanol or control diet as before,
injected with BrdU at T48, then allowed to survive 56 days. BrdU immunoreactivity remained
in similar locations (Figure 5 C, F) suggesting that these cells persist long term if not
permanently.
To identify what type of cells the new cells born on T48 become, a cell phenotype study was
performed using multiple fluorescent immunohistochemistry and confocal microscopy (Figure
6). The first phenotype study focused on the dentate gyrus and examined multiple labeling for
BrdU (newborn cell), NeuN (mature neuron) and GFAP (mature glia; representative images
in Figure 6). Figure 7 shows the percent of BrdU+ cells that also labeled with the various mature
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cell markers. As expected, ~75% of newborn cells in control animals co-expressed NeuN and
are considered newborn neurons (Figure 6, 7). However in the binge-ethanol exposed group
only 24% of BrdU+ cells co-labeled with NeuN (e.g. Figure 6C), a percentage that is
significantly different from the controls (p=0.003). For the mature glia marker, GFAP, BrdU
+ cells in control brains colabeled with this marker in 10% of newborn cells whereas in binge
Ethanol-exposed tissue, BrdU and GFAP colabeled in 20% of BrdU+ cells (p=n.s.).
Importantly, in the control brains, this triple labeling scheme identified the phenotype of nearly
90% of the newborn cells as neurons or astroglia, but in binge ethanol exposed brains, this
scheme only identified 40% of newborn cells. Therefore, a majority of cells born at T48 were
not identified by these mature neuron or mature glia markers. To identify these unidentified
BrdU+ cells, initially, we compared the aberrant pattern of BrdU expression in the molecular
layer and CA fields with the pattern of expression of other markers. Examination of single
label, DAB colorization on T48 + 28 day binge ethanol tissue only showed that the pattern of
expression of various immature neurons markers (doublecortin, β-Tubulin III) and an
oligodendrocyte marker (O4) were not similar to the pattern of BrdU+ cells (data not shown)
which then ruled out the likelihood that newborn cells were newborn neurons or newborn
oligodendrocytes. Next, a microglia marker (Iba-1) was examined in single label and based on
the distribution of Iba-1 across the hippocampus, we then examined Iba-1 and BrdU colabeling
in T48 + 28 day tissue. As is clearly shown in Table 3 and in representative images in Figure
8, very few BrdU+ cells colabeled with Iba-1 in control brains, whereas the majority of BrdU
+ cells in binge ethanol-exposed brains colabeled with Iba-1, a significant difference in new
cell phenotype. This colabeling between BrdU and Iba-1 was observed across all regions
examined in binge ethanol-exposed tissue at T48 + 28 days and similarly when phenotyping
was carried out on T48 + 56 day tissue (Table 3, Figure 7). For the neurogenic dentate gyrus
granule cell and SGZ, phenotype percentages were then multiplied by BrdU+ cells counts (of
fluorescent labeled BrdU+ cells in dentate gyrus/SGZ) to estimate effects on neurogenesis and
cell genesis. As shown in Figure 7B, the number of BrdU+ cells is significantly increased in
binge ethanol-exposed tissue (p=0.02). However when that increase in BrdU+ cells is
multiplied by the low percentage of neuronal phenotype (Figure 7A), the result is no net change
in calculated numbers of new neurons or “calculated neurogenesis” (Figure 7B). Further, when
BrdU+ cell number is multiplied by the percent phenotype for glia and microglia, there are
significant increases in both the calculated number of newborn astroglia [BrdU+/GFAP+/
NeuN-; p=0.04] and microglia [BrdU+/Iba-1+; p<0.01]. Thus, binge ethanol exposure induces
the proliferation of glia and predominantly microglia but does not alter neurogenesis at this
particular time point.
As proliferation of microglia is a hallmark of microglial activation and microglial activation
occurs after many cell death events in the brain, we examined the expression of a commonly
used marker of microglial activation ED-1 (also referred to as CD68). ED-1 expression
correlates with phagocytic activity (Damoiseaux et al., 1994), a characteristic of reactive
microglia and/or macrophages (Guillemin and Brew, 2004). As control brains express low to
minimal ED-1 protein, we included a positive control brain in these studies to verify ED-1
immunohistochemical labeling. The positive control, a piece of brain tissue from a rat given a
single 10 mg/kg dose of kainate and allowed to seize for several hours, showed vast ED-1
immunoreactivity characteristic of phagocytic or fully “activated” microglia. Neither control
brains nor T48 ethanol exposed brains showed significant ED-1 immunoreactivity within the
brain parenchyma, as shown in Figure 9. Indeed, this lack of ED-1 immunoreactivity is
consistent with the morphology of cells labeled with Iba-1 in the colabeling studies. Iba-1
positive cells appear ramified (see Figure 7), which is consistent with a non-phagocytic
activation state and thus, the lack of ED-1 immunoreactivity.
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These data are the first to directly show increased, newborn microglia in brain or microglia
proliferation in any model of alcohol exposure in vivo. Specifically, we report for the first time
that abstinence from ethanol, in a rodent model of an AUD, produces distinct peaks in brain
cell proliferation that are regionally and temporally specific. At two days after the last dose of
alcohol, BrdU+ cells were observed across the entire hippocampus, confirmed by the striking
and significant increase in BrdU+IR and Ki67+IR in the CA fields, dentate gyrus and molecular
layer. BrdU+ cells were also observed in distinct regions of cortex. Twenty-eight days later
(T48+28days), BrdU+ cells were observed in even more regions of cortex. Phenotypic analysis
of these newborn cells shows that the majority of new cells were not neurons. A large majority
of these new cells co-labeled with Iba-1, a marker unique to microglia. Thus, binge ethanol
exposure induces cell proliferation across the hippocampus and cortex that results in a long-
term increase in new microglia in brain that persist for at least a few months. Interestingly, this
mimics recent studies in post-mortem human alcoholic brain that found increased levels of
cytokines and markers of microglia in alcoholics, but not moderate drinkers (He et al., 2008).
Altogether, these data and our previous report on NSC proliferation/neurogenesis following
binge ethanol exposure indicate that two distinct peaks in cell proliferation occur: first
proliferation of microglia at T48 followed by proliferation of neuronal progenitors at T168
after binge exposure.
Though this is the first report showing microglial proliferation following binge alcohol
exposure, this effect is consistent with reports of cell proliferation in various models of brain
damage (Dash et al., 2001; Gould and Tanapat, 1997). Microglial proliferation is commonly
observed after cell death (Hailer et al., 1999) and this binge alcohol model produces neuronal
cell death (Collins et al., 1996; Obernier et al., 2002a; Zou et al., 1996). Specifically,
degenerating cells increase during the 4-day binge and peak at the fourth day of ethanol
intoxication (Figure 10; Crews et al., 2000; Obernier, 2002a;b). Neurodegeneration via ethanol
inhibition of neurogenesis in the dentate gyrus also continues during intoxication (Nixon and
Crews, 2002; 2004). Although the binge ethanol model has a significant withdrawal syndrome,
markers of neurodegeneration subside during withdrawal and abstinence: markers decrease
significantly by day 2–3 of abstinence and completely recede by 1 week (Figure 10; Crews et
al., 2000; 2004; Obernier et al., 2002a). Thus, these bursts in cell proliferation occur as the
degeneration and fragments of dying neurons clear.
Binge ethanol induced degeneration is localized primarily to association cortex, such as
piriform, perirhinal and entorhinal cortex, as well as the hippocampal dentate gyrus. We found
increased cell proliferation in limbic regions showing neurodegeneration as well as across
many cortical and non-cortical brain regions not previously thought to be damaged by binge
ethanol treatment. Studies of cell proliferation after brain insults have similarly found cell
genesis in regions not directly damaged. Entorhinal cortex lesions cause an increase in
proliferation of microglia 3 days later in dentate gyrus on both the lesion side and the
contralateral hippocampus suggesting that proliferation occurs in projection areas of the dying
neurons as well as in the cell body regions (Hailer et al. 1999). Similarly, focal electrolytic
lesions of the dentate gyrus result in increased proliferation in both the ipsilateral and
contralateral dentate gyrus (Ernst and Christie, 2006). Although binge ethanol induced
neurodegeneration is not observed in the same regions as those showing microglia proliferation
at T48, degeneration studies primarily focused on the loss of cell bodies. The loss of innervation
in the projection areas of damaged neurons is known to stimulate proliferation and/or migration
of microglia to deafferented regions (Fagan and Gage, 1994; Gall et al., 1979). Accordingly,
at T48+28days, broad areas of the cortex show new microglia that were not as prominent just
after labeling (T48) consistent with migration and/or honing to sites of damage/deafferentation
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(e.g. Figure 4b). Therefore, this report of vast cortical and hippocampal microgliosis at T48
+28 days and T48+56 days suggests novel regions of alcohol-induced damage.
We found that dentate gyrus proliferation increases from binge ethanol inhibited levels (T0)
to control levels after one day of abstinence that is followed by distinct increases in proliferation
during the first week of abstinence. Several other models of brain injury also have shown two
bursts in cell proliferation with microglia proliferation followed by neuronal progenitor
proliferation (Dash et al., 2001; Ernst and Christie, 2006; Rice et al., 2003). Indeed, this pattern
is identical to the full timecourse of cell proliferation events during ethanol withdrawal and
abstinence (Figure 1; Nixon and Crews, 2004). In models of traumatic brain injury and other
acute neurodegenerative events, microglia proliferation is commonly noted 1–2 days after cell
death though not necessarily 1–2 days after the event itself (Amat et al., 1996; Ernst and
Christie, 2006; Fagan and Gage, 1994; Gall et al., 1979; Marella and Chabry, 2004; Vela et
al., 2002; Williams et al., 1994). The specific timing of this increase in microglia proliferation
at T48 is consistent with other models of diffuse brain injury and specifically an injury that is
not direct (e.g. Ernst and Christie, 2006). Microglia proliferate within 12 to 24 hours in regions
immediately adjacent to a lesion, but more distal sites of retrograde or anterograde degeneration
may not have a proliferative reaction until 2 days (Vela et al., 2002). Remarkably, the pattern
of microglial proliferation in the hippocampus following binge ethanol treatment is identical
to that of a partially deafferented hippocampus (Gall et al., 1979). Hippocampal deafferentation
is consistent with binge ethanol-induced cell death in entorhinal/perirhinal cortices. Therefore,
the timing and pattern of microglial proliferation suggests a diffuse brain injury due to
excessive alcohol intake.
Microglia exist in multiple states that can range from anti-inflammatory and trophic secretion
of growth factors to phagocytic and pro-inflammatory. A role for microglia in alcohol-induced
brain damage has been suggested for years (Streit, 1994; Collins et al., 1998), though there are
no published reports of fully activated, or phagocytic, microglia in any in vivo AUD model.
Interestingly, human alcoholic brain shows increased microglia markers, but no signs of
increased proinflammatory microglia (He et al., 2008). Further, studies in animals have
reported that chronic ethanol can cause a long term increase in the density of [3H]PK-11195,
a ligand for the peripheral benzodiazepine receptor that is enriched in activated microglia
(Obernier et al., 2002b; Syapin and Alkana, 1988; Weissman et al., 2004). However, the
“activated” microglia marker for phagocytes, ED-1, is not expressed at T48 (Figure 9) nor any
other time point examined to date (data not shown). This effect is supported by the lack of
amoeboid-shaped microglia in any of the new microglia examined in this study (Figure 7) or
in past reports in cerebellum (Riikonen et al., 2002) or cortex (Crews et al., 2006a). Although
microglial proliferation is a sign of microglial activation, our studies are consistent with
microglia not activated to a proinflammatory state. Alcoholics, however, do not just binge once
and it must be considered that the increased microglia could heighten later responses to insults
that may then increase degeneration if microglia become fully activated. Alternatively, an
increase in anti-inflammatory microglia could contribute to the recovery of the brain during
abstinence (Raivich et al., 1999). Additional work is needed to fully understand the phenotype
of these new born microglia and how they contribute to brain degeneration and/or regeneration
in abstinence.
In summary, during the first week of abstinence following a 4-day binge ethanol treatment
there are distinct bursts of cell proliferation in many regions of the brain, particularly in the
hippocampus and cortex. At the early timepoint in abstinence, proliferating cells labeled with
BrdU are observed in multiple brain regions and largely differentiate into microglia. The late
burst of proliferating cells is restricted to the neurogenic subgranular zone of the dentate gyrus
and differentiates over several weeks mostly into neurons. These distinct cell genesis events
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during abstinence represent a unique and long-term change in brain cell structure that persists
for long periods and perhaps permanently.
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Distinct bursts in cell proliferation following binge ethanol exposure. A full timecourse of
changes in BrdU incorporation (cell proliferation) assessed from the number of BrdU+ cells/
mm2 in the dentate gyrus and SGZ following binge ethanol exposure and reported as a
percentage of control. Two distinct increases in cell proliferation are noted at 48 h after the last
dose of ethanol (T48) and as we have reported previously at T168. Error bars represent SEM.
*p<0.05.
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BrdU immunoreactivity is increased across the hippocampus. Increased cell proliferation as
indicated by increased BrdU incorporation is evident across most regions of the hippocampus
at T48 (A). Representative photomicrographs of BrdU immunoreactivity in the hippocampus
is shown for controls (B) and T48 ethanol treated tissue (D). BrdU staining of proliferating
cells was confirmed in adjacent tissue sections with Ki-67, an endogenous cell proliferation
marker as shown for controls (C) and binge ethanol exposed tissue (E). Error bars represent
SEM. *p<0.05.
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Aberrant cortical cell proliferation at T48 following binge ethanol exposure. At T48, a striking
pattern of BrdU+IR is noted in a few regions of cortex. BrdU+IR was examined only in those
areas with visually distinct immunoreactivity following binge exposure. BrdU+IR was
significantly increased in the motor and somatosensory cortices of ethanol exposed rats (n=6)
as opposed to controls (n=6) at T48. Error bars represent SEM. *p<0.05.
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Aberrant BrdU+ cells persist 1 month after binge ethanol exposure. In ethanol exposed rats
(EtOH), BrdU+ cells labeled at T48 remain in all regions of hippocampus and even more
regions of the cortex 28 days later (T48+28 days). Control brains (Con) have only a few BrdU
+ cells in the cortex and several in the dentate gyrus as expected in this neurogenic region. The
scattered pattern of BrdU+IR was more pronounced and in additional regions of cortex despite
ethanol treatment parameters being identical between the two timepoints, T48 and T48+28
days. Scale bar equals 200µm. Error bars are SEM. *p<0.05
Nixon et al. Page 17














BrdU+IR at T48+56 days in ethanol-exposed tissue is similar to that of T48+28 days.
Representative low magnification confocal images of control (A, D) versus ethanol-exposed
brains (B,C,E,F) where Green = BrdU+ cells, Red = NeuN immunoreactivity and Blue = GFAP
+ immunoreactivity. Though control brains (A,D) show the expected few BrdU+ cells (green)
in non neurogenic regions such as the CA fields and Molecular Layer (A), aberrant BrdU+
cells remain in all regions of the hippocampus of ethanol-exposed tissue, especially in CA
fields and the Molecular Layer after 28 (B) and 56 days (C). BrdU+ cells are visible in the
dentate gyrus of control brains (D, arrow) however BrdU+ cells (arrows) show a similar pattern
in ethanol-exposed tissue at T48 plus 28 days (E) and 56 days (F).
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(A) Representative confocal images are shown for fluorescent triple labeling of BrdU (new
cell, green), NeuN (neuron specific, red) and GFAP (astroglia specific, blue) or Iba-1
(microglia specific, blue) in the dentate gyrus of control and ethanol-exposed rats at T48
+28days. In controls, the majority of new (BrdU+) cells colabel with NeuN and thus are new
neurons (B). In ethanol exposed tissue at 28 and 56 days after being labeled with BrdU at T48
most new BrdU+ cells do not colabel with NeuN but do colabel with Iba1, a microglia specific
calcium binding protein (see Figure 8). In the dentate gyrus, colocalization of BrdU and NeuN
is confirmed in reconstructed Z-stacks (orthogonal view, LSM Image Examiner) for from
controls (red NeuN + green BrdU = yellow new neuron shown in B). The lack of colocalization
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between BrdU and NeuN in T48+28days ethanol-exposed tissue is shown in representative
images from T48+28 (C) and T48+56 (D) brain tissue. Importantly at no time did we observe
BrdU+/NeuN+ cells in the cortex, which supports that binge ethanol exposure does not induce
cortical neurogenesis at this time point.
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No net change in neurogenesis at day 30 despite proliferation effects at T48. Though BrdU+
cells are increased at day 30 of ethanol abstinence (i.e. T48+28 days) this increase is not in
new neurons. Differentiation percentages for BrdU+ cells in the dentate gyrus at T48+28 days
(A) were multiplied by BrdU+ cells counts (B, left side of graph) to roughly estimate
neurogenesis and gliogenesis. The increased number of BrdU+ cells (profile count) at T48+28
days in ethanol-exposed rats versus controls is obvious as shown in representative fluorescent
single label images of BrdU+ cells from a control (C) versus binge ethanol-exposed rats (D).
Thus, neurogenesis is not increased at this particular timepoint, however, new astroglia (GFAP
+/BrdU+ cells) are increased slightly and new microglia (Iba1+/BrdU+) cells are increased 6-
fold. Error bars represent SEM. *p<0.05.
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After binge ethanol exposure, most dividing cells at T48 become microglia. BrdU primarily
colabels with Iba-1, a microglia-specific marker, in ethanol treated tissue at T48 + 28 days.
Representative confocal images are shown for BrdU (a,d,g,j,m), Iba-1 (b,e,h,k,n), and the two
merged together (c,f,i,l,o) across cortex (a – f), hippocampus molecular layer (g–i)
hippocampus CA1 (j–l), and hippocampus hilus (m–o) in ethanol (d – o) and control (a–c only)
tissue. Representative 3-D reconstructed images (orthogonal view in LSM Image Examiner)
are shown for cortex (p), molecular layer (q) and CA1 fields (r) of ethanol treated tissue to
show how overlapping morphology in multiple Z-plane sections indicate colabeling.
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Lack of ED1 immunoreactivity for phagocytic microglia following binge ethanol exposure.
Immunohistochemistry for ED1 was performed on T48 ethanol (a) and control (b) treated tissue
along with positive control tissue (c, Kainate treated rat). As shown in panel A, no obvious
ED1-positive cells are apparent following binge ethanol exposure, however some staining
appears in the blood vessels (arrows). The morphology of these possible cells is dissimilar to
the obvious ED1-positive phagocytes shown in positive control tissue (C) and ED-1
immunoreactivity is similar between binge ethanol and control tissue.
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Temporal relationship of binge ethanol induced neurodegeneration and cell genesis. This figure
illustrates that bursts of cell genesis occur in the week following binge ethanol treatment but
overlap with neurodegeneration due to cell death. Neurodegenerative events (dashed-dotted
line) are represented as downward lines on the y-axis whereas regenerative events are
represented as upward lines (various lines as indicated in legend). The 4-day binge ethanol
model has been studied extensively as a model of alcohol dependence and alcohol induced
neurodegeneration. Multiple markers of neuronal cell death, particularly agyrophilic silver
stain, have characterized pyramidal cell degeneration in cortical and hippocampal regions over
the 4-day binge (Crews et al., 2000). Simultaneous to neuronal cell death during intoxication
is ethanol inhibition of neural progenitor cell proliferation, e.g. neurogenesis (dotted line).
Symptoms of physical withdrawal, including possible seizures, occur during the first 24 hrs
(lightning bolt) post ethanol binge. The T48 burst in microglia proliferation (dashed line) occurs
in multiple brain regions including the hippocampus and distinct regions of cortex. These new
cells persist at least 56 days if not permanently (Kempermann et al., 2003). The T168 burst in
progenitor cell proliferation is restricted primarily to the dentate gyrus and results in more new
neurons 1 month later (dotted line; see also Nixon and Crews, 2004).
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Table 1
Antibodies
Anti- (Source) Dilution Secondary used
BrdU (Chemicon) 1:4000 Biotinylated Horse anti-mouse
Ki-67 (Novacastra) 1:200 Biotinylated Horse anti-mouse
Iba-1 (Wako) 1:400 AlexaFluor goat anti-rabbit 546
BrdU (Accurate) 1:400 AlexaFluor goat anti-rat 488
NeuN (Chemicon) 1:500 AlexaFluor goat anti-mouse 633
GFAP (Dako) 1:2500 AlexaFluor goat anti-rabbit 546
ED-1 (CD68; Serotec) 1:400 Biotinylated Horse anti-mouse
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